Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Highly stable and luminescent CdS quantum dots (QD) were prepared in aqueous solutions via in situ capping of the crystals with the poly(acrylic acid) (
PAA
) and
mercaptoacetic acid
(MAA) binary mixtures. The effect of reaction temperature and coating composition on the particle size, colloidal stability and luminescence were investigated and discussed in detail. CdS QDs coated with either
PAA
or MAA were also prepared and compared in terms of properties. CdS-MAA QDs were highly luminescent but increasing reaction temperature caused an increase in the crystal size and a significant decrease in the quantum yield (QY). Although less luminescent and bigger than CdS-MAA, CdS-
PAA
QDs maintained the room temperature size and QY at higher reaction temperatures. CdS-MAA QDs lacked long-term colloidal stability whereas CdS-
PAA
QDs showed excellent stability over a year. Use of
PAA
/MAA mixture as a coating for CdS nanoparticles during the synthesis provided excellent stability, high QY and ability to tune the size and the color of the emission. Combination of all of these properties can be achieved only with the mixed coating. CdS coated with
PAA
/MAA at 40/60 ratio displayed the highest QY (50% of Rhodamine B) among the other compositions.
...
PMID:Development of highly stable and luminescent aqueous CdS quantum dots with the poly(acrylic acid)/mercaptoacetic acid binary coating system. 1945 36